Sweden
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.45 B
|
Dec. 31, 2023 | USD 26.00 | 1.16% |
|
Sweden |
|
2 |
USD 396.68 M
|
Dec. 31, 2023 | USD 28.08 | 0.23% |
|
Sweden |
|
3 |
USD 158.31 M
|
Dec. 31, 2023 | USD 16.63 | 0.49% |
|
Sweden |
|
4 |
USD 136.40 M
|
Dec. 31, 2023 | USD 3.30 | 3.88% |
|
Sweden |
|
5 |
USD 104.30 M
|
Dec. 31, 2023 | USD 17.18 | 2.59% |
|
Sweden |
|
6 |
USD 73.94 M
|
April 30, 2024 | USD 5.39 | -0.39% |
|
Sweden |
|
7 |
USD 62.97 M
|
Dec. 31, 2023 | USD 18.25 | 2.79% |
|
Sweden |
|
8 |
USD 58.90 M
|
Dec. 31, 2023 | USD 51.72 | -0.10% |
|
Sweden |
|
9 |
USD 45.90 M
|
Dec. 31, 2023 | USD 12.08 | 1.50% |
|
Sweden |
|
10 |
USD 40.26 M
|
Dec. 31, 2023 | USD 3.87 | 2.52% |
|
Sweden |
|
11 |
USD 37.23 M
|
Dec. 31, 2023 | USD 9.75 | -0.95% |
|
Sweden |
|
12 |
USD 34.64 M
|
Dec. 31, 2023 | USD 4.73 | 3.81% |
|
Sweden |
|
13 |
USD 29.83 M
|
Dec. 31, 2023 | USD 17.87 | 3.09% |
|
Sweden |
|
14 |
USD 25.46 M
|
Dec. 31, 2023 | USD 11.98 | -2.51% |
|
Sweden |
|
15 |
USD 24.34 M
|
Dec. 31, 2023 | USD 20.58 | 0.68% |
|
Sweden |
|
16 |
USD 18.62 M
|
Dec. 31, 2023 | USD 52.21 | -0.68% |
|
Sweden |
|
17 |
USD 15.53 M
|
Dec. 31, 2023 | USD 0.28 | 0.36% |
|
Sweden |
|
18 |
USD 11.30 M
|
Dec. 31, 2023 | USD 14.61 | 2.17% |
|
Sweden |
|
19 |
USD 10.85 M
|
Dec. 31, 2023 | USD 18.76 | 3.89% |
|
Sweden |
|
20 |
USD 6.84 M
|
April 30, 2024 | USD 22.17 | -0.20% |
|
Sweden |
|
21 |
USD 5.42 M
|
Dec. 31, 2023 | USD 2.09 | -2.04% |
|
Sweden |
|
22 |
USD 5.03 M
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
23 |
USD 3.10 M
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
24 |
USD 2.91 M
|
Dec. 31, 2023 | USD 2.19 | 0.18% |
|
Sweden |
|
25 |
USD 2.55 M
|
Dec. 31, 2023 | USD 1.35 | -1.92% |
|
Sweden |
|
26 |
USD 2.41 M
|
Dec. 31, 2023 | USD 19.07 | 4.08% |
|
Sweden |
|
27 |
USD 2.02 M
|
Dec. 31, 2023 | USD 0.14 | 1.34% |
|
Sweden |
|
28 |
USD 1.64 M
|
Dec. 31, 2023 | USD 0.97 | -2.02% |
|
Sweden |
|
29 |
USD 1.62 M
|
Dec. 31, 2023 | USD 2.57 | -0.02% |
|
Sweden |
|
30 |
USD 301.73 K
|
Dec. 31, 2023 | USD 0.11 | 4.03% |
|
Sweden |
|
31 |
USD 20.63 K
|
Dec. 31, 2023 | USD 3.31 | 2.33% |
|
Sweden |
|
32 |
USD -131.95 K
|
April 30, 2024 | USD 0.14 | 0.68% |
|
Sweden |
|
33 |
USD -135.32 K
|
Dec. 31, 2023 | USD 0.12 | 3.82% |
|
Sweden |
|
34 |
USD -199.28 K
|
Dec. 31, 2023 | USD 0.28 | 6.05% |
|
Sweden |
|
35 |
USD -391.31 K
|
Dec. 31, 2023 | USD 0.09 | 1.68% |
|
Sweden |
|
36 |
USD -393.12 K
|
Dec. 31, 2023 | USD 0.78 | 5.47% |
|
Sweden |
|
37 |
USD -479.09 K
|
Dec. 31, 2023 | USD 0.39 | 2.53% |
|
Sweden |
|
38 |
USD -960.84 K
|
Dec. 31, 2023 | USD 0.84 | -0.17% |
|
Sweden |
|
39 |
USD -1.06 M
|
Dec. 31, 2023 | USD 0.23 | -0.87% |
|
Sweden |
|
40 |
USD -1.09 M
|
Dec. 31, 2023 | USD 0.15 | 3.82% |
|
Sweden |
|
41 |
USD -1.29 M
|
Dec. 31, 2023 | USD 1.88 | 0.68% |
|
Sweden |
|
42 |
USD -1.36 M
|
Dec. 31, 2023 | USD 1.01 | -1.50% |
|
Sweden |
|
43 |
USD -1.87 M
|
Dec. 31, 2023 | USD 0.13 | -10.15% |
|
Sweden |
|
44 |
USD -2.00 M
|
Dec. 31, 2023 | USD 0.61 | 0.68% |
|
Sweden |
|
45 |
USD -2.05 M
|
Dec. 31, 2023 | USD 0.11 | 1.48% |
|
Sweden |
|
46 |
USD -2.19 M
|
Aug. 31, 2023 | USD 0.30 | -1.39% |
|
Sweden |
|
47 |
USD -2.21 M
|
April 30, 2024 | USD 1.60 | -0.43% |
|
Sweden |
|
48 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.11 | 1.51% |
|
Sweden |
|
49 |
USD -2.40 M
|
Dec. 31, 2023 | USD 32.97 | -0.61% |
|
Sweden |
|
50 |
USD -2.65 M
|
Dec. 31, 2023 | USD 0.93 | -6.21% |
|
Sweden |
The Pharmaceuticals company in Sweden with the highest Free Cash Flow is Essity AB (publ) (Stockholm Stock Exchange: ESSITY-B.ST) at USD 1.45 B.
The Pharmaceuticals company in Sweden with the lowest Free Cash Flow is Hansa Biopharma AB (publ) (Stockholm Stock Exchange: HNSA.ST) at USD -74.61 M.
The top 10 Pharmaceuticals companies in Sweden by Free Cash Flow are Essity AB (publ), Lifco AB (publ), Getinge AB (publ), Arjo AB (publ), Medicover AB (publ), Elekta AB (publ), Vitrolife AB (publ), Camurus AB (publ), AddLife AB (publ) and Swedencare AB (publ).
The bottom 10 Pharmaceuticals companies in Sweden by Free Cash Flow are Hansa Biopharma AB (publ), Vimian Group AB (publ), Swedish Orphan Biovitrum AB (publ), Vicore Pharma Holding AB (publ), BioInvent International AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), Egetis Therapeutics AB (publ), Xspray Pharma AB (publ) and Sedana Medical AB (publ).